Formats Link

-1

archive,paged,tax-post_format,term-post-format-link,term-85,paged-4,wp-theme-bridge,bridge-core-2.5.8,ajax_fade,page_not_loaded,,qode-theme-ver-24.3,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

Archive

Posted at 11 Sep, 13:41h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Announces Successful Product Retesting of AD04 for Phase 3 Clinical Trial

Posted at 09 May, 17:34h in Press Release by adialpharma 0 Comments

1 Like

Adial Pharmaceuticals Announces Collaboration Agreement with Eurofins for Genetic Biomarker Testing to Support Upcoming Phase 3 Clinical Trial for Alcohol Use Disorder

Posted at 29 Apr, 19:39h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceutical’s Chief Medical Officer Dr. Bankole Johnson Featured on NBC West Palm Beach, Florida Affiliate

Posted at 26 Mar, 13:22h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Announces Appointment of Bankole Johnson, M.D., as Chief Medical Officer

Posted at 28 Feb, 15:17h in News & Media by adialpharma 0 Comments

0 Likes

William Stilley, CEO of Adial Pharmaceuticals (NASDAQ: ADIL) sits down with BAF host Michelle Griego to discuss the company’s lead asset, AD04, as a potential genetically targeted treatment for alcohol and opioid use disorder.

Posted at 28 Feb, 15:13h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Featured on CBS in San Francisco

Posted at 20 Feb, 14:08h in Press Release by adialpharma 0 Comments

0 Likes

ADIAL PHARMACEUTICALS ANNOUNCES PARTNERSHIP WITH CATALENT TO PACKAGE AND DISTRIBUTE ADIAL’S AD04 FOR ITS PHASE 3 TRIAL

Posted at 12 Feb, 14:39h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Appoints Leading Addiction Specialist to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder

Posted at 07 Feb, 14:31h in Press Release by adialpharma 0 Comments

0 Likes

DR. BANKOLE A. JOHNSON, CHAIRMAN OF ADIAL PHARMACEUTICALS, RECEIVES PRESTIGIOUS AMERICAN SOCIETY OF ADDICTION MEDICINE AWARD

Posted at 01 Feb, 14:25h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals CEO to Appear on CBS and Fox Affiliates to Discuss AD04 as a Potential Treatment for Alcohol and Opioid Use Disorder

1
2
3
4
5
6